Dreavent Capital

Dreavent is an investment firm focused on Biotech Therapeutics companies. Our strategic location in the preeminent biotech hub, combined with a worldwide network of investors and partners, allows us to access high-quality companies that are impacting the future of healthcare and provide an asymmetric return profile. At Dreavent, our mission is to improve human health by advancing promising new therapies for important diseases currently lacking effective treatments. The Engine 2024, our ongoing Venture Fund, exemplifies this mission by rigorously selecting and investing in high-potential biotech companies. Our proactive evaluation process, competitive advantages, and strategic partnerships ensure that we focus on firms at the forefront of medical innovation, aiming to revolutionize treatment approaches and foster a healthier future.